Albumin fusion proteins
AssigneesNovozymes Biopharma DK A/S, Human Genome Sciences, Inc.
InventorsDavid J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
Life of this patent
Estimating the term…
Loading patent…
AssigneesNovozymes Biopharma DK A/S, Human Genome Sciences, Inc.
InventorsDavid J. Ballance, Darrell Sleep, Christopher P. Prior, Homayoun Sadeghi, Andrew J. Turner
Estimating the term…
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.
1-60. (canceled)
An albumin fusion protein comprising a von Willebrand Factor (vWF) polypeptide fused to an albumin polypeptide, wherein said vWF polypeptide fused to said albumin polypeptide has vWF activity, and wherein said albumin polypeptide is selected from:
Dependencies are inferred from the claim text.